Chinese Journal of New Drugs and Clinical Remedies 2005;24(4):253-262

Glucosamine sulfate: the first clinical proven disease modifying drug for osteoarthritis

Annefeld MARLIESE

Keywords

osteoarthritis; joint disease; drug therapy; joint space narrowing; glucosamine sulfate

Country

China

Language

Chinese

Abstract

The publish summarized three latest systemic reviews and given details of the landmark trail on glucosamine sulfate introduce the yesterday, today and a good future of disease modifying drug for osteoarthritis (DMOAD) on a view. It will helpful to promote the clinical, the assessment and the developing of DMOAD in China.